QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
| |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
|
| |
(Address of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
|
|
|
|
☒ |
Accelerated filer |
☐ | |||
Non-accelerated filer |
☐ |
Smaller reporting company |
| |||
Emerging growth company |
|
Page |
||||
3 |
||||
4 |
||||
5 |
||||
6 |
||||
7 |
||||
27 |
||||
38 |
||||
39 |
||||
40 |
||||
40 |
||||
40 |
||||
41 |
||||
41 |
||||
41 |
||||
41 |
||||
42 |
March 31, 2020 (Unaudited) |
December 31, 2019 |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | |
$ | |
||||
Commissions receivable, net |
|
|
||||||
Prepaid expenses |
|
|
||||||
Income tax receivable |
|
|
||||||
Marketable debt securities, available-for-sale (includes amortized cost and an allowance for credit losses of $ |
|
|
||||||
Advances and loans, net |
|
|
||||||
Other assets |
|
|
||||||
Total current assets |
|
|
||||||
Property and equipment, net |
|
|
||||||
Operating lease right-of-use assets, net |
|
|
||||||
Marketable debt securities, available-for-sale (includes amortized cost and an allowance for credit losses of $ |
|
|
||||||
Assets held in rabbi trust |
|
|
||||||
Deferred tax assets, net |
|
|
||||||
Goodwill and other intangible assets, net |
|
|
||||||
Advances and loans, net |
|
|
||||||
Other assets |
|
|
||||||
Total assets |
$ | |
$ | |
||||
Liabilities and stockholders’ equity |
||||||||
Current liabilities: |
||||||||
Accounts payable and other liabilities |
$ | |
$ | |
||||
Notes payable to former stockholders |
|
|
||||||
Deferred compensation and commissions |
|
|
||||||
Operating lease liabilities |
|
|
||||||
Accrued bonuses and other employee related expenses |
|
|
||||||
Total current liabilities |
|
|
||||||
Deferred compensation and commissions |
|
|
||||||
Operating lease liabilities |
|
|
||||||
Other liabilities |
|
|
||||||
Total liabilities |
|
|
||||||
Commitments and contingencies |
|
|
||||||
Stockholders’ equity: |
||||||||
Preferred stock, $ |
||||||||
Authorized shares – |
|
|
||||||
Common stock, $ |
||||||||
Authorized shares – |
|
|
||||||
Additional paid-in capital |
|
|
||||||
Stock notes receivable from employees |
( |
) | ( |
) | ||||
Retained earnings |
|
|
||||||
Accumulated other comprehensive income |
|
|
||||||
Total stockholders’ equity |
|
|
||||||
Total liabilities and stockholders’ equity |
$ | |
$ | |
||||
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Revenues: |
||||||||
Real estate brokerage commissions |
$ | |
$ |
|
||||
Financing fees |
|
|
||||||
Other revenues |
|
|
||||||
Total revenues |
|
|
||||||
Operating expenses: |
||||||||
Cost of services |
|
|
||||||
Selling, general and administrative expense |
|
|
||||||
Depreciation and amortization expense |
|
|
||||||
Total operating expenses |
|
|
||||||
Operating income |
|
|
||||||
Other (expense) income, net |
( |
) | |
|||||
Interest expense |
( |
) | ( |
) | ||||
Income before provision for income taxes |
|
|
||||||
Provision for income taxes |
|
|
||||||
Net income |
|
|
||||||
Other comprehensive (loss) income: |
||||||||
Marketable debt securities, available-for-sale: |
||||||||
Change in unrealized (losses) gains |
( |
) | |
|||||
Less: reclassification adjustment for net losses (gains) included in other (expense) income, net |
|
( |
) | |||||
Net change, net of tax of $( |
( |
) | |
|||||
Foreign currency translation gain (loss), net of tax of $ |
|
( |
) | |||||
Total other comprehensive income |
|
|
||||||
Comprehensive income |
$ | |
$ | |
||||
Earnings per share: |
||||||||
Basic |
$ | |
$ | |
||||
Diluted |
$ | |
$ | |
||||
Weighted average common shares outstanding: |
||||||||
Basic |
|
|
||||||
Diluted |
|
|
Three Months Ended March 31, 2020 |
||||||||||||||||||||||||||||||||||||
Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Stock Notes Receivable From Employees |
Retained Earnings |
Accumulated Other Comprehensive Income |
Total |
||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||
Balance at December 31, 2019 |
|
$ |
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Cumulative effect of a change in accounting principle, net of tax |
— |
|
— |
|
|
|
( |
) |
|
( |
) | |||||||||||||||||||||||||
Balance at January 1, 2020, as adjusted |
|
|
|
|
|
( |
) |
|
|
|
||||||||||||||||||||||||||
Net and comprehensive income |
— |
|
— |
|
|
|
|
|
|
|||||||||||||||||||||||||||
Stock-based award activity |
||||||||||||||||||||||||||||||||||||
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Issuance of common stock for vesting of restricted stock units |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Shares withheld related to net share settlement of stock-based awards |
|
|
( |
) |
|
( |
) |
|
|
|
( |
) | ||||||||||||||||||||||||
Balance as of March 31, 2020 |
|
$ |
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Three Months Ended March 31, 20 19 |
||||||||||||||||||||||||||||||||||||
Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Stock Notes Receivable From Employees |
Retained Earnings |
Accumulated Other Comprehensive Income |
Total |
||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||
Balance at December 31, 2018 |
|
$ |
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Net and comprehensive income |
— |
|
— |
|
|
|
|
|
|
|||||||||||||||||||||||||||
Stock-based award activity |
||||||||||||||||||||||||||||||||||||
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Issuance of common stock for vesting of restricted stock units |
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Shares withheld related to net share settlement of stock-based awards |
|
|
( |
) |
|
( |
) |
|
|
|
( |
) | ||||||||||||||||||||||||
Balance as of March 31, 2019 |
|
$ |
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Cash flows from operating activities |
||||||||
Net income |
$ | $ | ||||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Depreciation and amortization expense |
||||||||
Amortization of right-of-use assets |
||||||||
Credit loss recovery |
( |
) | ( |
) | ||||
Stock-based compensation |
||||||||
Deferred taxes, net |
||||||||
Unrealized f oreign exchange lo ss |
||||||||
Net realized (gains) losses on marketable debt securities, available-for-sale |
( |
) | ||||||
Other non-cash items |
||||||||
Changes in operating assets and liabilities: |
||||||||
Commissions receivable |
( |
) | ||||||
Prepaid expenses |
( |
) | ||||||
Advances and loans |
( |
) | ( |
) | ||||
Other assets |
( |
) | ( |
) | ||||
Accounts payable and other liabilities |
( |
) | ||||||
Income tax receivable/payable |
||||||||
Accrued bonuses and other employee related expenses |
( |
) | ( |
) | ||||
Deferred compensation and commissions |
( |
) | ( |
) | ||||
Operating lease liabilities |
( |
) | ( |
) | ||||
Other liabilities |
( |
) | ||||||
Net cash used in operating activities |
( |
) | ( |
) | ||||
Cash flows from investing activities |
||||||||
Acquisition, net of cash received |
( |
) | ||||||
Purchases of marketable debt securities, available-for-sale |
( |
) | ( |
) | ||||
Proceeds from sales and maturities of marketable debt securities, available-for-sale |
||||||||
Issuances of employee notes receivable |
( |
) | ||||||
Payments received on employee notes receivable |
||||||||
Purchase of property and equipment |
( |
) | ( |
) | ||||
Net cash provided by investing activities |
||||||||
Cash flows from financing activities |
||||||||
Taxes paid related to net share settlement of stock-based awards |
( |
) | ( |
) | ||||
Principal payments on stock appreciation rights liability |
( |
) | ||||||
Net cash used in financing activities |
( |
) | ( |
) | ||||
Effect of currency exchange rate changes on cash and cash equivalents |
( |
) |
||||||
Net decrease in cash and cash equivalents |
( |
) | ( |
) | ||||
Cash and cash equivalents at beginning of period |
||||||||
Cash and cash equivalents at end of period |
$ | $ | ||||||
Supplemental disclosures of cash flow information |
||||||||
Interest paid during the period |
$ | $ | ||||||
Income taxes paid, net |
$ | $ | ||||||
1. |
Description of Business and Basis of Presentation |
2. |
Accounting Policies and Recent Accounting Pronouncements |
3. |
Property and Equipment, Net |
March 31, 2020 |
December 31, |
|||||||
Computer software and hardware equipment |
$ | |
$ | |
||||
Furniture, fixtures, and equipment |
|
|
||||||
Less: accumulated depreciation and amortization |
( |
) | ( |
) | ||||
$ | |
$ | |
|||||
4. |
Operating Leases |
|
Three Months Ended March 31, |
|||||||
|
2020 |
2019 |
||||||
Operating lease cost: |
||||||||
Lease cost (1) |
$ |
|
$ |
|
||||
Variable lease cost (2) |
|
|
||||||
Sublease income |
( |
) | ( |
) | ||||
$ | |
$ | |
|||||
(1) |
Includes short-term lease cost and ROU asset amortization. |
(2) |
Primarily relates to common area maintenance, property taxes, insurance, utilities and parking. |
March 31, |
||||
Remainder of 2020 |
$ | |
||
2021 |
|
|||
2022 |
|
|||
2023 |
|
|||
2024 |
|
|||
Thereafter |
|
|||
Total future minimum lease payments |
|
|||
Less imputed interest |
( |
) | ||
Present value of operating lease liabilities |
$ | |
||
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Operating cash flow information: |
||||||||
Cash paid for amounts included in the measurement of operating lease liabilities |
$ | |
$ | |
||||
Noncash activity: |
||||||||
ROU assets obtained in exchange for operating lease liabilities |
$ |
|
$ |
|
||||
Tenant improvements owned by lessor related to ROU assets (1) |
$ | |
$ | |
(1) |
Reclassification from other assets current. |
March 31, 2020 |
December 31, 2019 |
|||||||
Weighted average remaining operating lease term |
|
|
||||||
Weighted average discount rate |
|
% | |
% |
5. |
Investments in Marketable Debt Securities |
March 31, 2020 |
||||||||||||||||||||
Amortized Cost |
Allowance for Credit Losses |
Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value |
||||||||||||||||
Short-term investments: |
||||||||||||||||||||
U.S. treasuries |
$ |
$ | $ | $ | $ | |||||||||||||||
U.S. government sponsored entities |
||||||||||||||||||||
Corporate debt |
( |
) | ||||||||||||||||||
ABS and other |
( |
) | ||||||||||||||||||
$ | $ | $ | $ | ( |
) | $ | ||||||||||||||
Long-term investments: |
||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | $ | |||||||||||||||
U.S. government sponsored entities |
||||||||||||||||||||
Corporate debt |
( |
) | ||||||||||||||||||
ABS and other |
( |
) | ||||||||||||||||||
$ | $ | $ | $ | ( |
) | $ | ||||||||||||||
December 31, 2019 |
||||||||||||||||
Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value |
|||||||||||||
Short-term investments: |
||||||||||||||||
U.S. treasuries |
$ | $ | $ | ( |
) | $ | ||||||||||
U.S. government sponsored entities |
||||||||||||||||
Corporate debt |
||||||||||||||||
$ | $ | $ | ( |
) | $ |
|||||||||||
Long-term investments: |
||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | ||||||||||||
U.S. government sponsored entities |
( |
) | ||||||||||||||
Corporate debt |
( |
) | ||||||||||||||
ABS and other |
( |
) | ||||||||||||||
$ | $ | $ | ( |
) | $ | |||||||||||
March 31, 2020 |
||||||||||||||||||||||||
Less than 12 months |
12 months or |
Total |
||||||||||||||||||||||
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
|||||||||||||||||||
Corporate debt |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||
ABS and other |
( |
) | ( |
) | ||||||||||||||||||||
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | |||||||||||||||
December 31, 2019 |
||||||||||||||||||||||||
Less than 12 months |
12 months or greater |
Total |
||||||||||||||||||||||
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
|||||||||||||||||||
U.S. treasuries |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||
U.S. government sponsored entities |
( |
) | ( |
) | ||||||||||||||||||||
Corporate debt |
( |
) | ( |
) | ||||||||||||||||||||
ABS and other |
( |
) | ( |
) | ||||||||||||||||||||
$ |
$ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | |||||||||||||
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Gross realized gains (1) |
$ |
$ |
||||||
Gross realized losses (1) |
$ | $ | ( |
) | ||||
(1) |
Recorded in other (expense) income, net in the condensed consolidated statements of net and comprehensive income. The cost basis of securities sold were determined based on the specific identification method. |
March 31, 2020 |
December 31, 2019 |
|||||||||||||||
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
|||||||||||||
Due in one year or less |
$ | $ | $ | $ | ||||||||||||
Due after one year through five years |
||||||||||||||||
Due after five years through ten years |
||||||||||||||||
Due after ten years |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
Weighted average contractual maturity |
6. |
Acquisitions, Goodwill and Other Intangible Assets |
March 31, 2020 |
December 31, 2019 |
|||||||||||||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Book Value |
Gross Carrying Amount |
Accumulated Amortization |
Net Book Value |
|||||||||||||||||||
Goodwill and intangible assets: |
||||||||||||||||||||||||
Goodwill (1) |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Intangible assets (2) |
( |
) | ( |
) | ||||||||||||||||||||
$ | $ | ( |
) | $ | $ | $ | ( |
) | $ | |||||||||||||||
(1) |
Represents additions from acquisitions. |
(2) |
Total weighted average amortization period was |
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance |
$ |
$ |
||||||
Additions from acquisitions |
||||||||
Impairment losses |
||||||||
Ending balance |
$ | $ | ||||||
March 31, 2020 |
||||
Remainder of 2020 |
$ | |||
2021 |
||||
2022 |
||||
2023 |
||||
2024 |
||||
Thereafter |
||||
$ | ||||
7. |
Selected Balance Sheet Data |
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance |
$ | $ | ||||||
Credit loss recovery |
( |
) | ( |
) | ||||
Write-offs |
( |
) | ( |
) | ||||
Ending balance |
$ | $ | ||||||
Current |
Non-Current |
|||||||||||||||
March 31, 2020 |
December 31, 2019 |
March 31, 2020 |
December 31, 2019 |
|||||||||||||
Mortgage servicing rights (“MSRs”), net of amortization |
$ | $ | $ | $ | ||||||||||||
Security deposits |
||||||||||||||||
Employee notes receivable (1) |
||||||||||||||||
Customer trust accounts and other |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
(1) |
Reduction of accrued bonuses and other employee related expenses in settlement of employee notes receivable were $ |
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance |
$ | $ | ||||||
Additions from acquisition |
||||||||
Additions |
||||||||
Amortization |
( |
) | ( |
) | ||||
Ending balance |
$ | $ | ||||||
Current |
Non-Current |
|||||||||||||||
March 31, 2020 |
December 31, 2019 |
March 31, 2020 |
December 31, 2019 |
|||||||||||||
Stock appreciation rights (“SARs”) liability (1) |
$ | $ | $ | $ | ||||||||||||
Commissions payable to investment sales and financing professionals |
||||||||||||||||
Deferred compensation liability (1) |
||||||||||||||||
Other |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
(1) |
The SARs and deferred compensation liability become subject to payout as a result of a participant no longer being considered as a service provider. As a result of the retirement of certain participants, estimated amounts to be paid to the participants within the next twelve months have been classified as current. |
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
(Decrease) increase in the carrying value of the assets held in the rabbi trust (1) |
$ | ( |
) | $ | ||||
(Decrease) increase in the net carrying value of the deferred compensation obligation (2) |
$ | ( |
) | $ | ||||
(1) |
Recorded in other (expense) income, net in the condensed consolidated statements of net and comprehensive income. |
(2) |
Recorded in selling, general and administrative expense in the condensed consolidated statements of net and comprehensive income. |
Non-Current |
||||||||
March 31, 2020 |
December 31, 2019 |
|||||||
Deferred consideration and other (1) (2) |
$ | $ | ||||||
Contingent consideration (1) (2) |
||||||||
$ | $ | |||||||
(1) |
The current portions of deferred consideration in the amounts of $ |
(2) |
Deferred consideration in the aggregate amount of $ non-current portions, respectively. |
8. |
Notes Payable to Former Stockholders |
9. |
Related-Party Transactions |
10. |
Fair Value Measurements |
• | Level 1: |
• | Level 2: |
• | Level 3: |
March 31, 2020 |
December 31, 2019 |
|||||||||||||||||||||||||||||||
Fair Value |
Level 1 |
Level 2 |
Level 3 |
Fair Value |
Level 1 |
Level 2 |
Level 3 |
|||||||||||||||||||||||||
Assets: |
||||||||||||||||||||||||||||||||
Assets held in rabbi trust |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||
Cash equivalents (1) : |
||||||||||||||||||||||||||||||||
Commercial paper and other |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||
Money market funds |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
|||||||||||||||||
Marketable debt securities, available-for-sale: |
||||||||||||||||||||||||||||||||
Short-term investments: |
||||||||||||||||||||||||||||||||
U.S. treasuries |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||
U.S. government sponsored entities |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Corporate debt |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
ABS and other |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
|||||||||||||||||
Long-term investments: |
||||||||||||||||||||||||||||||||
U.S. treasuries |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||
U.S. government sponsored entities |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Corporate debt |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
ABS and other |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
|||||||||||||||||
Liabilities: |
||||||||||||||||||||||||||||||||
Contingent consideration |
$ | |
$ | |
$ | |
$ | |
$ | $ | |
$ | |
$ | ||||||||||||||||||
Deferred compensation liability |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||||||
(1) |
Included in cash and cash equivalents on the accompanying condensed consolidated balance sheets. |
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance (1) |
$ | $ | ||||||
Contingent consideration in connection with acquisitions (2) |
||||||||
Change in fair value of contingent consideration |
( |
) | ||||||
Payments of contingent consideration |
||||||||
Ending balance |
$ | $ |
||||||
(1) |
Beginning balance for 2020 reflects the reclassification of $ |
(2) |
Contingent consideration in connections with acquisitions represents a noncash investing activity. |
Fair Value at March 31, 2020 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||
Contingent consideration |
$ |
Discounted cash flow |
Expected life of cash flows |
|||||||||
Discount rate |
||||||||||||
Probability of achievement |
||||||||||||
Fair Value at December 31, 2019 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||
Contingent consideration |
$ |
Discounted cash flow |
Expected life of cash flows |
|||||||||
Discount rate |
||||||||||||
Probability of achievement |
(1) |
Unobservable inputs were weighted by the relative fair value of the instruments. |
Fair Value at March 31, 2020 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||
MSRs |
$ |
Discounted cash flow |
Constant prepayment rates |
|||||||||
Constant default rate |
||||||||||||
Loss severity |
||||||||||||
Discount rate |
Fair Value at December 31, 2019 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||
MSRs |
$ |
Discounted cash flow |
Constant prepayment rates |
|||||||||
Constant default rate |
||||||||||||
Loss severity |
||||||||||||
Discount rate |
(1) |
Weighted average is based on the | % constant prepayment rate scenario which the Company uses as the reported fair value.
11. |
Stockholders’ Equity |
12. |
Stock-Based Compensation Plans |
RSA Grants to Non-employee Directors |
RSU Grants to Employees |
RSU Grants to Independent Contractors |
Total |
Weighted- Average Grant Date Fair Value Per Share |
||||||||||||||||
Nonvested shares at December 31, 2019 |
$ | |||||||||||||||||||
Granted |
||||||||||||||||||||
Vested |
( |
) | ( |
) | ( |
) | ||||||||||||||
Transferred |
( |
) | ||||||||||||||||||
Forfeited/canceled |
( |
) | ( |
) | ( |
) | ||||||||||||||
Nonvested shares at March 31, 2020 (1) |
$ | |||||||||||||||||||
Unrecognized stock-based compensation expense as of March 31, 2020 (2) |
$ | $ | $ | $ | ||||||||||||||||
Weighted average remaining vesting period (years) as of March 31, 2020 |
||||||||||||||||||||
(1) |
Nonvested RSUs will be settled through the issuance of new shares of common stock. |
(2) |
The total unrecognized compensation expense is expected to be recognized over a weighted-average period of approximately |
March 31, 2020 |
||||
2021 |
||||
2022 |
||||
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
ESPP |
$ | $ | ||||||
RSAs – non-employee directors |
||||||||
RSUs – employees (1) |
||||||||
RSUs – independent contractors |
||||||||
$ | $ | |||||||
(1) |
Includes expense related to the acceleration of vesting of certain RSUs. |
13. |
Income Taxes |
Three Months Ended March 31, |
||||||||||||||||
2020 |
2019 |
|||||||||||||||
Amount |
Rate |
Amount |
Rate |
|||||||||||||
Income tax expense at the federal statutory rate |
$ | % | $ | % | ||||||||||||
State income tax expense, net of federal benefit |
% | % | ||||||||||||||
Windfall tax benefits, net related to stock-based compensation |
( |
) | ( |
)% | ( |
) | ( |
)% | ||||||||
Change in valuation allowance |
% | % | ||||||||||||||
Permanent and other items (1) |
% | % | ||||||||||||||
$ |
% | $ |
% | |||||||||||||
(1) | Permanent items relate principally to compensation charges, qualified transportation fringe benefits, reversal of uncertain tax positions, meals and entertainment and our tax-exempt deferred compensation plan assets. |
14. |
Earnings per Share |
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Numerator (Basic and Diluted): |
||||||||
Net income |
$ | $ | ||||||
Denominator: |
||||||||
Basic |
||||||||
Weighted average common shares issued and outstanding |
||||||||
Deduct: Unvested RSAs (1) |
( |
) | ( |
) | ||||
Add: Fully vested DSUs (2) |
||||||||
Weighted Average Common Shares Outstanding |
||||||||
Basic earnings per common share |
$ | $ | ||||||
Diluted |
||||||||
Weighted Average Common Shares Outstanding from above |
||||||||
Add: Dilutive effect of RSUs, RSAs & ESPP |
||||||||
Weighted Average Common Shares Outstanding |
||||||||
Diluted earnings per common share |
$ | $ | ||||||
Antidilutive shares excluded from diluted earnings per common share (3) |
||||||||
(1) |
RSAs were issued and outstanding to the non-employee directors and have a -year or -year vesting term subject to service requirements. See Note 12 – “Stock-Based Compensation Plans” for additional information. |
(2) |
Shares are included in weighted average common shares outstanding as the shares are fully vested but have not yet been delivered. See Note 12 – “Stock-Based Compensation Plans” for additional information. |
(3) |
Primarily pertaining to RSU grants to the Company’s employees and independent contractors. |
15. |
Commitments and Contingencies |
16. |
Subsequent Events |
• | Properties priced less than $1 million; |
• | Private client market: |
• | Middle market: |
• | Larger transaction market: |
Three Months Ended March 31, |
||||||||||||||||||||||||||||||||||||
2020 |
2019 |
Change |
||||||||||||||||||||||||||||||||||
Real Estate Brokerage |
Number |
Volume |
Revenues |
Number |
Volume |
Revenues |
Number |
Volume |
Revenues |
|||||||||||||||||||||||||||
(in millions) |
(in thousands) |
(in millions) |
(in thousands) |
(in millions) |
(in thousands) |
|||||||||||||||||||||||||||||||
<$1 million |
216 |
$ | 136 |
$ | 5,742 |
201 |
$ | 131 |
$ | 5,288 |
15 |
$ | 5 |
$ | 454 |
|||||||||||||||||||||
Private client market ($1 - $10 million) |
1,242 |
4,001 |
114,264 |
1,060 |
3,320 |
96,058 |
182 |
681 |
18,206 |
|||||||||||||||||||||||||||
Middle market ( ≥ $10 - $20 million) |
91 |
1,222 |
22,668 |
92 |
1,245 |
23,580 |
(1 |
) | (23 |
) | (912 |
) | ||||||||||||||||||||||||
Larger transaction market ( ≥ $20 million) |
66 |
3,083 |
29,155 |
52 |
2,407 |
20,011 |
14 |
676 |
9,144 |
|||||||||||||||||||||||||||
1,615 |
$ | 8,442 |
$ | 171,829 |
1,405 |
$ | 7,103 |
$ | 144,937 |
210 |
$ | 1,339 |
$ | 26,892 |
||||||||||||||||||||||
Three Months Ended March 31, |
||||||||
Real Estate Brokerage |
2020 |
2019 |
||||||
Average Number of Investment Sales Professionals |
1,889 |
1,818 |
||||||
Average Number of Transactions per Investment Sales Professional |
0.85 |
0.77 |
||||||
Average Commission per Transaction |
$ | 106,396 |
$ | 103,158 |
||||
Average Commission Rate |
2.04 |
% | 2.04 |
% | ||||
Average Transaction Size (in thousands) |
$ | 5,227 |
$ | 5,056 |
||||
Total Number of Transactions |
1,615 |
1,405 |
||||||
Total Sales Volume (in millions) |
$ | 8,442 |
$ | 7,103 |
||||
Three Months Ended March 31, |
||||||||
Financing (1) |
2020 |
2019 |
||||||
Average Number of Financing Professionals |
89 |
106 |
||||||
Average Number of Transactions per Financing Professional |
5.37 |
3.66 |
||||||
Average Fee per Transaction |
$ | 30,900 |
$ | 33,541 |
||||
Average Fee Rate |
0.84 |
% | 0.89 |
% | ||||
Average Transaction Size (in thousands) |
$ | 3,670 |
$ | 3,763 |
||||
Total Number of Transactions |
478 |
388 |
||||||
Total Financing Volume (in millions) |
$ | 1,754 |
$ | 1,460 |
(1) |
Operating metrics calculated excluding certain financing fees not directly associated with transactions. |
Three Months Ended March 31, 2020 |
Percentage of Revenue |
Three Months Ended March 31, 2019 |
Percentage of Revenue |
Change |
||||||||||||||||||||
Dollar |
Percentage |
|||||||||||||||||||||||
Revenues: |
||||||||||||||||||||||||
Real estate brokerage commissions |
$ | 171,829 |
90.1 |
% | $ | 144,937 |
90.2 |
% | $ | 26,892 |
18.6 |
% | ||||||||||||
Financing fees |
15,351 |
8.0 |
13,732 |
8.5 |
1,619 |
11.8 |
% | |||||||||||||||||
Other revenues |
3,537 |
1.9 |
2,038 |
1.3 |
1,499 |
73.6 |
% | |||||||||||||||||
Total revenues |
190,717 |
100.0 |
160,707 |
100.0 |
30,010 |
18.7 |
% | |||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Cost of services |
113,757 |
59.6 |
91,688 |
57.1 |
22,069 |
24.1 |
% | |||||||||||||||||
Selling, general and administrative expense |
54,860 |
28.8 |
48,918 |
30.4 |
5,942 |
12.1 |
% | |||||||||||||||||
Depreciation and amortization expense |
2,464 |
1.3 |
1,832 |
1.1 |
632 |
34.5 |
% | |||||||||||||||||
Total operating expenses |
171,081 |
89.7 |
142,438 |
88.6 |
28,643 |
20.1 |
% | |||||||||||||||||
Operating income |
19,636 |
10.3 |
18,269 |
11.4 |
1,367 |
7.5 |
% | |||||||||||||||||
Other (expense) income, net |
(366 |
) | (0.2 |
) | 3,375 |
2.1 |
(3,741 |
) | (110.8 |
)% | ||||||||||||||
Interest expense |
(283 |
) | (0.1 |
) | (349 |
) | (0.2 |
) | 66 |
(18.9 |
)% | |||||||||||||
Income before provision for income taxes |
18,987 |
10.0 |
21,295 |
13.3 |
(2,308 |
) | (10.8 |
)% | ||||||||||||||||
Provision for income taxes |
5,917 |
3.1 |
5,657 |
3.6 |
260 |
4.6 |
% | |||||||||||||||||
Net income |
$ | 13,070 |
6.9 |
% | $ | 15,638 |
9.7 |
% | $ | (2,568 |
) | (16.4 |
)% | |||||||||||
Adjusted EBITDA (1) |
$ | 22,378 |
11.7 |
% | $ | 23,159 |
14.4 |
% | $ | (781 |
) | (3.4 |
)% | |||||||||||
(1) |
Adjusted EBITDA is not a measurement of our financial performance under U.S. generally accepted accounting principles (“U.S. GAAP”) and should not be considered as an alternative to net income, operating income or any other measures derived in accordance with U.S. GAAP. For a definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to net income, see “Non-GAAP Financial Measure.” |
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Net income |
$ | 13,070 |
$ | 15,638 |
||||
Adjustments: |
||||||||
Interest income and other (1) |
(2,003 |
) | (2,541 |
) | ||||
Interest expense |
283 |
349 |
||||||
Provision for income taxes |
5,917 |
5,657 |
||||||
Depreciation and amortization |
2,464 |
1,832 |
||||||
Stock-based compensation |
2,632 |
2,341 |
||||||
Non-cash MSR activity (2) |
15 |
(117 |
) | |||||
Adjusted EBITDA (3) |
$ | 22,378 |
$ | 23,159 |
||||
(1) |
Other includes net realized gains (losses) on marketable debt securities available-for-sale. |
(2) |
Non-cash MSR activity includes the assumption of servicing obligations. |
(3) |
The decrease in Adjusted EBITDA for the three months ended March 31, 2020 compared to the same period in 2019 is primarily due to a higher proportion of operating expenses compared to total revenues. |
Three Months Ended March 31, |
||||||||
2020 |
2019 |
|||||||
Net cash used in operating activities |
$ | (52,793 |
) | $ | (38,598 |
) | ||
Net cash provided by investing activities |
13,097 |
24,073 |
||||||
Net cash used in financing activities |
(2,940 |
) | (2,026 |
) | ||||
Effect of currency exchange rate changes on cash and cash equivalents |
(274 |
) | — |
|||||
Net decrease in cash and cash equivalents |
(42,910 |
) | (16,551 |
) | ||||
Cash and cash equivalents at beginning of period |
232,670 |
214,683 |
||||||
Cash and cash equivalents at end of period |
$ | 189,760 |
$ | 198,132 |
||||
Change in Interest Rates |
Approximate Change in Fair Value of Investments Increase (Decrease) |
|||
2% Decrease |
$ | 2,703 |
||
1% Decrease |
$ | 1,469 |
||
1% Increase |
$ | (2,114 |
) | |
2% Increase |
$ | (4,228 |
) |
• | Any impairment in value of our investments in marketable debt securities, available-for-sale, tangible or intangible assets, which could be recorded as a result of weaker economic conditions. |
• | A potential negative impact on the health of our employees and investment sales and financing professionals, particularly if a significant number of them are impacted, could result in a deterioration in our ability to ensure business continuity during a disruption. |
• | If significant portions of our workforce are unable to work effectively, including because of quarantines, facility closures, ineffective remote work arrangements or technology failures or limitations, our operations would be adversely impacted. |
Exhibit No. |
Description | |||
10.1* |
||||
31.1* |
||||
31.2* |
||||
32.1** |
||||
101 |
The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Net and Comprehensive Income, (iii) Condensed Consolidated Statements of Stockholders’ Equity, (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags. | |||
104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* |
Filed herewith. |
** |
Furnished, not filed. |
Marcus & Millichap, Inc . | ||||||
Date: |
May 11, 2020 |
By: |
/s/ Hessam Nadji | |||
Hessam Nadji President and Chief Executive Officer (Principal Executive Officer) | ||||||
Date: |
May 11, 2020 |
By: |
/s/ Martin E. Louie | |||
Martin E. Louie Chief Financial Officer (Principal Financial Officer) |